Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. World Health Organization. Global report on diabetes. Geneva: WHO Press; 2016.
2. Rosen J, Yosipovitch G. Skin manifestations of diabetes mellitus. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2018.
3. Jedlowski PM, Te CH, Segal RJ, et al. Cutaneous adverse effects of diabetes mellitus medications and medical devices: a review. Am J Clin Dermatol. 2019;20(1):97–114.
4. Deng N, Zhang X, Zhao F, et al. Prevalence of lipohypertrophy in insulin-treated diabetes patients: a systematic review and meta-analysis. J Diabetes Investig. 2017.
https://doi.org/10.1111/jdi.12742
.
5. Al Ajlouni M, Abujbara M, Batieha A, et al. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus. Int J Endocrinol Metab. 2015;13(2):e20776.